Barclays remains a buy for UBS and RBC despite third-quarter earnings miss
Source: proactiveinvestors.com

Barclays' third-quarter results fell short of market expectations, but UBS maintained its buy rating and RBC Capital Markets reiterated outperform. UBS trimmed its price target to 588p from 590p, while RBC held its 525p target; the reference share price was 409p.
Analysis
The key signal is not that two brokers remain positive; it is that a reported earnings miss has so far produced little change in their published conviction. That may cushion near-term sentiment, but broker targets are not independent evidence that earnings estimates have troughed. If the miss reflects persistent pressure on net interest income, costs, or credit quality, estimate cuts can follow after the initial analyst response and overwhelm target-price support. Conversely, a one-off miss with stable forward guidance could limit the risk of multiple compression across UK banks. The article does not identify the miss’s drivers, the share-price reaction, or changes to forecasts, so there is no sound basis for a directional position. Also, the quoted targets and reference price are in pence for the London listing; they should not be compared directly with the supplied NYSE BCS identity without verifying the ADR ratio and FX. Over the next 1–3 months, focus on revisions to forward earnings, management guidance, impairments, deposit pricing, and capital-return plans. A sustained deterioration in those indicators would falsify the supportive-analyst thesis; stable or improving guidance would strengthen it.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
-0.10
Ticker Sentiment
Key Decisions for Investors
- Do not buy solely on the reiterated ratings or headline target upside. First verify the earnings-miss drivers, forward estimate revisions, and the market’s post-results price response.
- Treat BCS as a watch, not an immediate long or short. Reassess after the next company guidance or results catalyst; a long case needs evidence that earnings estimates and capital returns are holding up.
- For any valuation comparison, reconcile the London pence targets with NYSE BCS using the current ADR ratio and FX; the article’s figures are not directly comparable to the supplied ticker.
- Falsification watch: further downward revisions to earnings or capital-return guidance, or worsening credit indicators, would argue that broker support is lagging fundamentals; stable forward guidance and improving revisions would weaken the bearish case.
More News
- Here are Friday's biggest analyst calls: Nvidia, SpaceX, CoreWeave, Deckers, Unusual Machines & more
- Why is Lancashire stock sliding today?
- Next week brings major risks for the stock market, just as the AI trade keeps faltering
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- Looters hit 3,000 French businesses. Within hours, the haul was trending on Vinted under the riot’s date
- Apple’s $2,000 iPhone Duo Debuts With Limited Supply
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Sector Analysis, Improvements on Research Data, and Performance Enhancements
- Choosing an AI Copilot for Equity Research